HOMA-IR explained: what is a good score and how to interpret yours
Health

HOMA-IR explained: what is a good score and how to interpret yours

HOMA-IR explained: the formula, the score thresholds for insulin sensitivity vs resistance, and what to do with your number — without needing a glucose tolerance test.

#homa-ir #insulin-resistance #fasting-insulin #glucose #biomarker #metabolic-health #longevity #lab-interpretation

You see “HOMA-IR” on a longevity blood panel and have no idea what it means. The number is 1.8. Is that good? Bad? Compared to what?

HOMA-IR — the Homeostatic Model Assessment of Insulin Resistance — is one of the most useful single numbers in metabolic health. It takes two cheap, routine blood tests (fasting glucose and fasting insulin) and combines them into a score that estimates how insulin-resistant you are right now. No glucose tolerance test, no clamp study, no expensive equipment. Just two numbers and a calculator.

But the number only matters if you know how to read it. This article walks you through the formula, the threshold values, what a good score looks like, and what to actually do with yours.

What you’ll learn:

  • The HOMA-IR formula and how to calculate yours from your blood work
  • The threshold scores for insulin sensitivity, early resistance, and full insulin resistance
  • Why HOMA-IR catches metabolic dysfunction that fasting glucose alone misses
  • How to lower your HOMA-IR through lifestyle interventions

What is HOMA-IR?

HOMA-IR is a calculated score that estimates how much insulin your body needs to keep your blood glucose normal. The lower the number, the more insulin-sensitive you are. The higher the number, the more insulin-resistant.

Quick definition: HOMA-IR is the product of your fasting glucose and fasting insulin, divided by a constant. Lower scores mean better insulin sensitivity.

The model was published by Matthews et al. in 1985 and has been one of the most widely used insulin-resistance estimates in clinical research and longevity medicine ever since. It’s not perfect — gold-standard insulin-sensitivity measurements use the hyperinsulinemic-euglycemic clamp — but HOMA-IR captures roughly 80-85% of the clamp’s information at a tiny fraction of the cost.

For more context on insulin and aging, our guide on fasting insulin as a biomarker covers why insulin matters far beyond diabetes risk.


The HOMA-IR formula

The standard formula uses fasting glucose in mg/dL (US units) or mmol/L (international units).

US units (mg/dL)

HOMA-IR = (fasting insulin × fasting glucose) / 405
  • Fasting insulin in µIU/mL (microunits per mL)
  • Fasting glucose in mg/dL

International units (mmol/L)

HOMA-IR = (fasting insulin × fasting glucose) / 22.5
  • Fasting insulin in µIU/mL
  • Fasting glucose in mmol/L

Worked example

Your fasting insulin is 8 µIU/mL. Your fasting glucose is 95 mg/dL.

HOMA-IR = (8 × 95) / 405 = 760 / 405 = 1.88

A HOMA-IR of 1.88 sits in the early-elevated zone — not yet diabetic, but past the optimal sensitivity range. We’ll get to thresholds in a moment.


HOMA-IR threshold scores: what is a good number?

There’s no single universal cutoff for HOMA-IR — different populations show different distributions. But several decades of research and clinical use have settled on practical interpretation zones.

Interpretation zones

HOMA-IR Zone What it means
< 1.0 Optimal sensitivity Lean, well-trained metabolic profile
1.0 - 1.5 Healthy sensitivity Most healthy adults
1.5 - 2.0 Early elevation Subtle insulin resistance forming
2.0 - 2.9 Insulin resistance Established metabolic dysfunction, often without symptoms
3.0 - 4.9 Significant resistance Pre-diabetic territory, even with normal fasting glucose
≥ 5.0 Severe resistance Strong association with type 2 diabetes risk

These ranges are typical for adult populations from research literature. For some longevity-oriented practitioners, the goal is HOMA-IR below 1.0, on the basis that the lowest scores associate with the best metabolic and cardiovascular profiles in cohort studies.

What “good for longevity” looks like

For longevity-focused readers, the practical targets are:

  • Optimal: HOMA-IR under 1.0 with fasting insulin under 5 µIU/mL
  • Healthy: HOMA-IR under 1.5 with fasting insulin under 8 µIU/mL
  • Action threshold: HOMA-IR above 1.5, regardless of fasting glucose

The reason action starts before “diabetic” thresholds is that insulin resistance precedes hyperglycemia by years to decades. By the time fasting glucose crosses into pre-diabetic range, you’ve usually been insulin-resistant for a long time.


Why HOMA-IR matters when fasting glucose is normal

The most common scenario where HOMA-IR earns its keep: fasting glucose looks normal, but insulin resistance is already established.

The slow road to type 2 diabetes

Insulin resistance develops in three rough stages:

  1. Early compensation. Your body makes more insulin to keep glucose normal. Glucose stays in range. Fasting insulin rises silently.
  2. Established resistance. Insulin keeps rising. Glucose stays normal but is starting to drift. HOMA-IR is now elevated.
  3. Beta-cell failure. Your pancreas can’t keep producing enough insulin. Glucose finally rises. HbA1c crosses into pre-diabetic range. Now everyone notices.

Stages 1 and 2 are the years where HOMA-IR matters most. Fasting glucose alone misses them. HbA1c alone misses them. Only fasting insulin — and HOMA-IR — surface the dysfunction early.

For a deeper look at the comparison, see our guide on fasting insulin vs HbA1c vs glucose and CGM vs fasting insulin for metabolic aging.


HOMA-IR vs fasting insulin alone: which is better?

HOMA-IR is essentially fasting insulin × glucose / a constant. So why bother with the calculation if you already have fasting insulin?

When HOMA-IR adds value

  • Glucose is creeping up. Once fasting glucose drifts toward 100 mg/dL (5.6 mmol/L), HOMA-IR captures the combined signal of higher insulin plus higher glucose, both of which point to worsening metabolic health. Fasting insulin alone misses the glucose component.
  • Population comparison. HOMA-IR has more published normal-range data and threshold studies than fasting insulin alone, making it easier to compare your number to peers.
  • Tracking over time. HOMA-IR captures both axes simultaneously, so a single number reflects the full glucose-insulin story.

When fasting insulin alone is enough

  • Glucose is solidly normal. If your fasting glucose is consistently in the 75-90 mg/dL (4.2-5.0 mmol/L) range, fasting insulin alone tells you almost everything you need to know.
  • You want a simpler signal. Fasting insulin alone is more intuitive (“how much insulin am I making at rest?”). HOMA-IR is a derived score.

For most longevity-tracking purposes, track both: fasting insulin for the cleanest single number, HOMA-IR for the combined glucose-insulin score.


How to lower your HOMA-IR

The good news: HOMA-IR is one of the most responsive biomarkers in longevity medicine. It often shifts within weeks, not years.

High-impact levers (4-12 weeks of change)

  • Reduce ultra-processed foods and added sugar. The single biggest lever for most people. Dropping refined carbs, sweetened drinks, and ultra-processed snacks lowers fasting insulin and HOMA-IR fast.
  • Add resistance training 2-3 times per week. Muscle is the largest insulin-sensitive tissue in the body. Building muscle directly improves how efficiently your body handles glucose. Strength training tends to outperform pure cardio for HOMA-IR improvement in sedentary adults.
  • Add zone 2 cardio 3-4 times per week. Low-intensity steady-state cardio improves mitochondrial density and insulin sensitivity over weeks to months.
  • Improve sleep quality. Even one week of poor sleep significantly worsens insulin sensitivity. Targeting 7-9 hours of consistent sleep is non-negotiable for HOMA-IR improvement.
  • Lose visceral fat. A modest 5-10% body weight reduction, when fat loss is concentrated in the abdomen, often shifts HOMA-IR by 30-50%.

Medium-impact levers

  • Time-restricted eating. A 10-12 hour daily eating window can lower fasting insulin and HOMA-IR even without calorie reduction in many people.
  • Increase fiber intake. Soluble fiber slows glucose absorption and improves insulin sensitivity over weeks.
  • Reduce alcohol. Frequent drinking elevates fasting insulin and worsens insulin signaling. Reducing intake helps HOMA-IR.
  • Manage chronic stress. Cortisol elevates blood glucose and worsens insulin sensitivity. HRV-guided stress management can support metabolic improvement.

Lower-priority levers (still real, just smaller)

  • Berberine, inositol, or other supplements with insulin-sensitivity data — discuss with your clinician
  • Cinnamon, vinegar, and other dietary additions with modest published effects
  • Cold exposure or sauna with emerging but still-developing data

HOMA-IR and biological age

Insulin resistance is one of the most important drivers of accelerated biological aging. Why? Because chronically elevated insulin damages multiple systems at once:

  • Glycates proteins and accelerates AGE (advanced glycation end-product) accumulation
  • Drives systemic low-grade inflammation
  • Promotes visceral fat deposition and metabolic syndrome
  • Impairs autophagy and cellular cleanup
  • Worsens cardiovascular risk independently of glucose

Multiple cohort studies show that elevated HOMA-IR predicts higher all-cause mortality, faster cognitive decline, and accelerated cardiovascular aging. People with HOMA-IR in the lowest quartile typically live longer and healthier than those in the highest quartile, even when current weight and BMI are similar.

This is why insulin sensitivity is one of the most important levers in any biological-age improvement plan. Lowering HOMA-IR from 2.5 to 1.0 over 6-12 months is one of the most powerful interventions you can make for biological age. Our guide on how biological age is calculated covers the broader picture.


How to interpret your HOMA-IR in context

A single HOMA-IR number is informative; understanding the context makes it actionable. Three contextual checks turn a raw score into a real plan.

Check 1: What’s your fasting insulin doing?

If HOMA-IR is 2.0 and fasting insulin is 12 with glucose at 95 -> insulin compensation is rising; the resistance is real. For age-banded context on what these fasting insulin numbers mean, see fasting insulin normal range by age.

If HOMA-IR is 2.0 and fasting insulin is 8 with glucose at 105 -> glucose is starting to rise; you may be moving from compensation toward beta-cell stress.

These two patterns look the same in a single HOMA-IR number but represent different stages of metabolic dysfunction.

Check 2: What’s your HbA1c doing?

HbA1c reflects average glucose over the prior 8-12 weeks. If HOMA-IR is 2.0 with HbA1c at 5.4% (35 mmol/mol), your glucose has been stable; resistance is in early stages. If HOMA-IR is 2.0 with HbA1c at 5.9% (41 mmol/mol), your glucose is already drifting; the resistance is more advanced.

Check 3: What’s your trajectory?

A HOMA-IR of 2.0 measured once is a snapshot. A HOMA-IR that has moved from 1.0 -> 1.5 -> 2.0 over three years is a trajectory — and that trajectory matters far more than the current value.


How SuperAge uses HOMA-IR in your aging picture

Most longevity tools surface HOMA-IR as a single number on a dashboard. SuperAge treats it as one signal in a larger metabolic picture.

Automatic HOMA-IR calculation

When you upload blood work that includes fasting glucose and fasting insulin, SuperAge calculates HOMA-IR automatically and tracks it across visits.

Trajectory visualization

The app plots your HOMA-IR over time alongside fasting insulin, fasting glucose, and HbA1c — so you can see whether your metabolic profile is improving, stable, or drifting.

Integration with biological age

HOMA-IR is one of the most important inputs to a multi-system biological-age estimate. SuperAge weights it appropriately so improvements in insulin sensitivity show up in your overall aging trajectory.

Personalized intervention prompts

When HOMA-IR drifts up, the app surfaces likely drivers from your wearable data — sleep loss, training volume drop, stress signals from HRV — alongside diet and lifestyle suggestions tailored to the pattern.

Continuous wearable proxy

While HOMA-IR itself requires a blood draw, your daily wearable signals (resting heart rate, HRV, sleep quality, training volume) act as a soft proxy. The app can flag periods where metabolic stress is rising even before your next blood draw confirms it.


Frequently asked questions

What is a good HOMA-IR score?

For longevity, a HOMA-IR under 1.0 is optimal, with under 1.5 being healthy. Above 1.5 suggests early insulin resistance is forming, even if fasting glucose looks normal.

Can HOMA-IR be high if my fasting glucose is normal?

Yes — and this is actually the most important reason to test it. Insulin resistance compensates for years before glucose rises. A HOMA-IR of 2.5 with normal fasting glucose is common and signals real metabolic dysfunction.

How quickly can I lower HOMA-IR?

HOMA-IR is one of the more responsive biomarkers. Significant changes are common within 8-12 weeks of consistent dietary and exercise changes. Some people see drops of 30-50% in 12 weeks with focused effort.

Is HOMA-IR accurate enough to trust?

For tracking individual changes over time, yes. For absolute precision against gold-standard insulin-sensitivity measurement, HOMA-IR captures most of the signal but misses some nuance. The clamp test remains the research gold standard but is impractical outside research settings.

Should I get HOMA-IR tested if my doctor doesn’t order it routinely?

If you’re focused on metabolic health and longevity, yes — ask for fasting insulin alongside your fasting glucose. The cost is typically $20-$40 and the information density is high.

Is HOMA-IR useful in athletes or very active people?

Yes, and especially so. Athletes can have low fasting glucose but elevated insulin from chronic dietary load — HOMA-IR catches this where glucose alone wouldn’t. Athletes typically aim for HOMA-IR well under 1.0.

Does intermittent fasting lower HOMA-IR?

Generally yes, especially time-restricted eating with a 10-12 hour daily window. The mechanism is partly insulin sensitivity improvement and partly modest weight loss when applied consistently.


Key takeaways

  • HOMA-IR is a calculated score that estimates insulin resistance from fasting glucose and fasting insulin. Lower is better.
  • For longevity, target HOMA-IR under 1.0; healthy adults sit under 1.5; above 1.5 signals early insulin resistance worth addressing.
  • HOMA-IR catches metabolic dysfunction years before fasting glucose or HbA1c does. Compensatory hyperinsulinemia happens long before glucose rises.
  • The score is highly responsive to lifestyle change. Diet quality, resistance training, zone 2 cardio, sleep, and visceral fat reduction can drop HOMA-IR by 30-50% in 12 weeks for many people.
  • Trajectory matters more than a single number. Track HOMA-IR alongside fasting insulin and HbA1c across visits to see the real story.
  • Insulin sensitivity is one of the most important biological-age levers because elevated insulin damages multiple aging-related systems simultaneously.

Start tracking your insulin sensitivity today

Insulin resistance is the silent driver of metabolic aging. The earlier you catch it, the easier it is to reverse — and a HOMA-IR score from a routine blood draw is the cheapest tool you have to see it coming.

Ready to track HOMA-IR alongside your full longevity panel? Download SuperAge and start tracking your insulin sensitivity, biological age, and full metabolic profile in one place.


For a more specific decision guide, see HOMA-IR vs fasting insulin: which is easier to act on?.

References

  1. Matthews, D. R., et al. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia.
  2. Wallace, T. M., et al. (2004). Use and abuse of HOMA modeling. Diabetes Care.
  3. Bonora, E., et al. (1998). Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. Journal of Clinical Endocrinology & Metabolism.
  4. Reaven, G. M. (1988). Banting lecture 1988. Role of insulin resistance in human disease. Diabetes.
  5. Levine, M. E., et al. (2018). An epigenetic biomarker of aging for lifespan and healthspan. Aging.

Last updated: 2026-04-30. This article is regularly reviewed to ensure accuracy. The information provided does not replace professional medical advice. Consult your healthcare provider before making changes based on lab results or starting new interventions.

Written by SuperAge Team

The SuperAge Team writes evidence-informed guides on biological age, longevity biomarkers, Apple Health, wearables, and practical healthspan tracking.